In experimental models of ALI, the administration of endothelial cell-derived EVs attenuates the activation of endothelial nitric oxide synthase (eNOS), reducing the levels of NO and impairing vasodilation (Densmore et al., 2006). Here, NOS3 is linked to acute respiratory distress syndrome.